Sertraline Treatment of Children and Adolescents With Obsessive‐Compulsive Disorder or Depression: Pharmacokinetics, Tolerability, and Efficacy
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 37 (4) , 386-394
- https://doi.org/10.1097/00004583-199804000-00016
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Desipramine Pharmacokinetics When Coadministered With Paroxetine or Sertraline in Extensive MetabolizersJournal of Clinical Psychopharmacology, 1997
- Obsessive-Compulsive Disorder in a Birth Cohort of 18-Year-Olds: Prevalence and PredictorsJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placeboBiological Psychiatry, 1995
- A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorderInternational Clinical Psychopharmacology, 1995
- Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive DisorderArchives of General Psychiatry, 1995
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Acute Fluvoxamine PoisoningJournal of International Medical Research, 1993
- SertralineDrugs, 1992
- Toleration and Safety of SertralineInternational Clinical Psychopharmacology, 1991
- Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorderAmerican Journal of Psychiatry, 1988